Cristina Nita, Laura Groseanu, Daniela Opris, Denisa Predeteanu, Violeta Bojinca, Florian Berghea, Violeta Vlad, Mihai Abobului, Cosmin Constantinescu, Magdalena Negru, Ioana Saulescu, Sanziana Daia, Diana Mazilu, Andreea Borangiu, Claudia Cobilinschi, Denisse Mardale, Madalina Rosu, Andra Balanescu
Patients with immune-mediated rheumatic disease-related calcinosis comprise a subgroup at risk of encountering a more severe clinical outcome. Early assessment is pivotal for preventing overall disease progression, as calcinosis is commonly overlooked until several years into the disease and is considered as a 'non-lethal' manifestation. This single-center retrospective study explored the prevalence, clinical associations, and impact on survival of subcutaneous calcinosis in 86 patients with immune-mediated rheumatic diseases (IMRD)...
March 18, 2024: Diagnostics